FDAClass IIDecember 27, 2017

Neostigmine Methylsulfate recall: Labeling Error

Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs.…

Why was Neostigmine Methylsulfate recalled?

Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018

Product
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs.…
Recalling firm
Premier Pharmacy Labs Inc
Quantity
1610 syringes
Distribution
Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
Recall date
December 27, 2017
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls